JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) 3-Year Book Growth Rate : -24.80% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co 3-Year Book Growth Rate?

JW (Cayman) Therapeutics Co's Book Value per Share for the quarter that ended in Dec. 2023 was $0.57.

During the past 12 months, JW (Cayman) Therapeutics Co's average Book Value per Share Growth Rate was -30.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was -24.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of JW (Cayman) Therapeutics Co was -24.80% per year. The lowest was -24.80% per year. And the median was -24.80% per year.

Competitive Comparison of JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate falls into.

JW (Cayman) Therapeutics Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

JW (Cayman) Therapeutics Co (OTCPK:JWCTF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

JW (Cayman) Therapeutics Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines